EX-23.3 5 a16-18402_1ex23d3.htm EX-23.3

Exhibit 23.3

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors

China Cord Blood Corporation:

 

We consent to the use of our report dated July 31, 2015, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31, 2015, and the related consolidated statements of comprehensive income, changes in equity, and cash flows for the years ended March 31, 2014 and 2015, incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.

 

/s/ KPMG

 

Hong Kong, China
September 21, 2016